<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cold Spring Harb Mol Case Stud</journal-id>
<journal-id journal-id-type="iso-abbrev">Cold Spring Harb Mol Case Stud</journal-id>
<journal-id journal-id-type="hwp">cshmcs</journal-id>
<journal-id journal-id-type="pmc">cshmcs</journal-id>
<journal-id journal-id-type="publisher-id">cshmcs</journal-id>
<journal-title-group>
<journal-title>Cold Spring Harbor Molecular Case Studies</journal-title>
</journal-title-group>
<issn pub-type="epub">2373-2873</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28667000</article-id>
<article-id pub-id-type="pmc">5701307</article-id>
<article-id pub-id-type="doi">10.1101/mcs.a001941</article-id>
<article-id pub-id-type="medline">Steinberg-ShemerMCS001941</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole-exome sequencing identifies an α-globin cluster triplication resulting in increased clinical severity of β-thalassemia</article-title>
<alt-title alt-title-type="left-running">α-Globin triplication identified by WES</alt-title>
<alt-title alt-title-type="right-running">α-Globin triplication identified by WES</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Steinberg-Shemer</surname>
<given-names>Orna</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="author-notes" rid="FN1">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ulirsch</surname>
<given-names>Jacob C.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="author-notes" rid="FN1">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noy-Lotan</surname>
<given-names>Sharon</given-names>
</name>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krasnov</surname>
<given-names>Tanya</given-names>
</name>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Attias</surname>
<given-names>Dina</given-names>
</name>
<xref ref-type="aff" rid="af7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dgany</surname>
<given-names>Orly</given-names>
</name>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laor</surname>
<given-names>Ruth</given-names>
</name>
<xref ref-type="aff" rid="af7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sankaran</surname>
<given-names>Vijay G.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamary</surname>
<given-names>Hannah</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Departments of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tivka 49202, Israel;</aff>
<aff id="af2"><label>2</label>Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel;</aff>
<aff id="af3"><label>3</label>Division of Hematology/Oncology, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA;</aff>
<aff id="af4"><label>4</label>Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA;</aff>
<aff id="af5"><label>5</label>Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA;</aff>
<aff id="af6"><label>6</label>Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva 49414, Israel;</aff>
<aff id="af7"><label>7</label>Pediatric Hematology/Oncology Unit, Bnai Zion Medical Center, Haifa 31048, Israel</aff>
<author-notes>
<fn fn-type="equal" id="FN1">
<label>8</label>
<p>These authors contributed equally to this work.</p>
</fn>
<corresp>Corresponding author: <email>htamary@post.tau.ac.il</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2017</year>
</pub-date>
<volume>3</volume>
<issue>6</issue>
<elocation-id>a001941</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>2</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.cshlp.org/site/misc/terms.xhtml">© 2017 Steinberg-Shemer et al.; Published by Cold Spring Harbor Laboratory Press</ext-link>
</copyright-statement>
<copyright-year>2017</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial License</ext-link>, which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="Steinberg-ShemerMCS001941.pdf"></self-uri>
<abstract>
<p>Whole-exome sequencing (WES) has been increasingly useful for the diagnosis of patients with rare causes of anemia, particularly when there is an atypical clinical presentation or targeted genotyping approaches are inconclusive. Here, we describe a 20-yr-old man with a lifelong moderate-to-severe anemia with accompanying splenomegaly who lacked a definitive diagnosis. After a thorough clinical workup and targeted genetic sequencing, we identified a paternally inherited β-globin mutation (<italic>HBB</italic>:c.93-21G&gt;A, IVS-I-110:G&gt;A), a known cause of β-thalassemia minor. As this mutation alone was inconsistent with the severity of the anemia, we performed WES. Although we could not identify any relevant pathogenic single-nucleotide variants (SNVs) or small indels, copy-number variant (CNV) analyses revealed a likely triplication of the entire α-globin cluster, which was subsequently confirmed by multiplex ligation-dependent probe amplification. Treatment and follow-up was redefined according to the diagnosis of β-thalassemia intermedia resulting from a single β-thalassemia mutation in combination with an α-globin cluster triplication. Thus, we describe a case where the typical WES-based analysis of SNVs and small indels was unrevealing, but WES-based CNV analysis resulted in a definitive diagnosis that informed clinical decision-making. More generally, this case illustrates the value of performing CNV analysis when WES is otherwise unable to elucidate a clear genetic diagnosis.</p>
</abstract>
<kwd-group>
<kwd>hypochromic microcytic anemia</kwd>
<kwd>reduced beta/alpha synthesis ratio</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution>National Institutes of Health </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>R01 DK103794</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution>National Institute of Diabetes and Digestive and Kidney Diseases </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000062</institution-id>
</institution-wrap>
</funding-source>
<award-id>R33 HL120791</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>
<institution-wrap>
<institution>National Heart, Lung, and Blood Institute </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000050</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
<body><sec id="s1" sec-type="introduction"><title>INTRODUCTION</title><p>Whole-exome sequencing (WES) has been remarkably successful at helping clinicians and researchers identify pathogenic single-nucleotide variants (SNVs) or small indels that result in severe disease (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C34">Sankaran et al. 2012</xref>, <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C35">2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C33">Sankaran and Gallagher 2013</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C40">Yang et al. 2013</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C20">Lacy et al. 2016</xref>). In a smaller number of cases, rare copy-number variants (CNVs) that are inferred from differences in WES read coverage have also been identified as pathogenic variants (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C6">de Ligt et al. 2013</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C29">Poultney et al. 2013</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C18">Kelsen et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C26">Miyatake et al. 2015</xref>). Typically, however, putative CNV calls are not a component of the clinical sequencing deliverables. Indeed, WES-based CNV calls are generally of lower quality than whole-genome sequencing (WGS), microarray, or array comparative genomic hybridization-based calls (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C31">Samarakoon et al. 2014</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C1">Belkadi et al. 2015</xref>), although these approaches have additional cost when compared with WES-based CNV calling when WES data are already available.</p><p>β-Thalassemia intermedia is typically caused by mutations that affect copies of the β-globin gene that limit, but do not completely abrogate, the production of functional β-globin chains, resulting in a moderate anemia, often with iron overload and other comorbidities (for review, see <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C39">Vichinsky 2016</xref>). The presence of a heterozygous β-globin mutation concurrent with a triplication of the α-globin gene have been described in a number of patients with a clinical presentation ranging from thalassemia minor to intermedia (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C16">Kanavakis et al. 1983</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C32">Sampietro et al. 1983</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C11">Galanello et al. 1983</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C37">Thein et al. 1984</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C14">Henni et al. 1985</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C3">Camaschella et al. 1987</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C19">Kulozik et al. 1987</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C28">Oron et al. 1994</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C38">Traeger-Synodinos et al. 1996</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C2">Bianco et al. 1997</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C12">Giordano et al. 2009</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C9">Farashi et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C25">Mehta et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C4">Clark et al. 2016</xref>). In most cases, the genetic changes were ααα<sup>anti3.7</sup>, the counterpart of the α<sup>−3.7</sup> deletion, the most common deletion of the α-globin locus, which spans 3.7 kb and involves both the α2- and α1-globin genes. This genetic change is easily detectable by restriction endonuclease mapping or multiplex Gap-PCR (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C23">Liu et al. 2000</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C7">de Mare et al. 2010</xref>). Here, we performed WES and searched for pathogenic variants in a 20-yr-old man who was initially clinically diagnosed with a rare congenital form of anemia (congenital dyserythropoietic anemia or CDA). Although we could not identify any pathogenic SNVs or indels in the known CDA genes, WES-based CNV analysis revealed an α-globin triplication that was coinherited with a heterozygous β-globin mutation, resulting in a definitive diagnosis of β-thalassemia intermedia that impacted the ongoing clinical management of this patient.</p></sec><sec id="s2" sec-type="results"><title>RESULTS</title><sec id="s2a"><title>Clinical Presentation</title><p>At the age of 18, the patient was first referred to our hematology clinic at the Schneider Children's Medical Center of Israel for evaluation of a lifelong anemia. Medical records showed that at 8 mo of age hemoglobin of 7 g/dl (normal: 10.5–14 g/dl) was noted, while MCV was 62 fl (normal: 73–85 fl). Reticulocyte count was 4%, LDH and indirect bilirubin were elevated, and iron status and thyroid function tests were normal. The father was of Eastern-European origin and the mother was an Ashkenazi Jew. The parents were nonconsanguineous. Upon presentation to our clinic, a physical examination was performed. The patient appeared jaundiced and his spleen was palpated 12 cm below the costal margin. The patient also developed cholelithiasis. Hemoglobin levels ranged between 7 and 9 g/dl, whereas the MCV ranged between 62 and 70 fl. A bone marrow aspiration revealed erythroid hyperplasia with mild dyserythropoiesis, a few binucleated erythroid precursors, and some megaloblastic changes (<xref ref-type="fig" rid="STEINBERG-SHEMERMCS001941F1">Fig. 1</xref>). Iron staining revealed no evidence of sideroblastic anemia. A thorough workup was performed to rule out enzymopathies, including glucose 6-phosphate dehydrogenase, pyruvate kinase, phosphofructokinase, glucosephosphate isomerase, phosphoglycerate kinase, and aldolase deficiency. Membrane defects were ruled out by the osmotic fragility test.</p><fig id="STEINBERG-SHEMERMCS001941F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Bone marrow morphology of the patient demonstrating erythroid hyperplasia (<italic>A</italic>) and dyserythropoietic changes (<italic>B</italic>). Scale bar, 50 µM.</p></caption><graphic xlink:href="Steinberg-ShemerMCS001941_F1"></graphic></fig><p>A molecular workup revealed that the patient was a carrier of the <italic>HBB</italic>:c.93-21G&gt;A (IVS-I-110:G&gt;A) mutation in the β-globin gene (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C41">Young et al. 1985</xref>). The father was found to carry the same mutation, although he had not previously come to clinical attention for this mild case of β-thalassemia minor. Therefore, the presence of one copy of the mutated allele was unlikely to be sufficient to cause the severe lifelong anemia and morphological changes observed and additional genetic causes were investigated. Sequencing and multiplex gap-PCR of the α-globin gene did not reveal any abnormalities, including the α<sup>−3.7</sup> deletion and ααα<sup>anti3.7</sup> triplication (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C23">Liu et al. 2000</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C7">de Mare et al. 2010</xref>). Given the mild dyserythropoiesis, the CDA genes (<italic>CDAN1</italic>, <italic>C15ORF41</italic>, <italic>SEC23B</italic>, <italic>KIF23</italic>, <italic>KLF1</italic>, and <italic>GATA1</italic>) were sequenced but no pathogenic variants could be identified.</p></sec><sec id="s2b"><title>Genomic Analyses</title><p>Given the unrevealing results of the targeted genetic approaches, whole-exome sequencing was performed on the patient (<ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a001941/-/DC1">Supplemental Table 1</ext-link>). Forty-six candidate erythroid genes were first investigated for rare (ExAC AF &lt; 0.01%) and potentially damaging (loss-of-function or missense) mutations, but no candidate variants for the anemia could be identified. Given that our typical WES-based SNV and small indel analysis was also unrevealing, we decided to call putative CNVs using WES read coverage. This analysis resulted in the identification of eight putative CNVs (<xref ref-type="table" rid="STEINBERG-SHEMERMCS001941TB1">Table 1</xref>) that were present at a frequency of &lt;5% in control samples. Inspection of these rare putative CNVs revealed a possible triplication of the α-globin cluster (Chr16:160473-240621), in addition to the known mutation in the β-globin gene (<xref ref-type="fig" rid="STEINBERG-SHEMERMCS001941F2">Fig. 2</xref>). Although maternal DNA was not available to determine the exact inheritance pattern, multiplex ligation-dependent probe amplification (MLPA) confirmed that the patient harbored a large triplication of the whole α-globin cluster including <italic>HBA1</italic>, <italic>HBA2</italic>, and <italic>HS40-HBQ1-3</italic> (<xref ref-type="fig" rid="STEINBERG-SHEMERMCS001941F3">Fig. 3</xref>). No other complete genes were present in this triplication event. Importantly, this triplication was larger than would be detected with typical multiplex gap-PCR approaches.</p><fig id="STEINBERG-SHEMERMCS001941F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Coverage differences in whole-exome sequencing revealed the possibility of an α-globin locus triplication. (<italic>A</italic>) Plot of principal component analysis (PCA)-normalized <italic>z</italic>-scores of mean centered read coverages across α-globin locus for 216 controls (gray) and case (red). Deviation from the control distribution of these scores indicates the presence of a likely deletion or duplication. Multimapped reads were allowed given the high homology between <italic>HBA1</italic> and <italic>HBA2</italic> in order to estimate the full length of the CNV event. (<italic>B</italic>) Plot of PCA-normalized <italic>z</italic>-scores for specific bait targeting <italic>HBA1</italic> exon 3.</p></caption><graphic xlink:href="Steinberg-ShemerMCS001941_F2"></graphic></fig><fig id="STEINBERG-SHEMERMCS001941F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>MLPA verifies a triplication of the whole α-globin cluster. (<italic>A</italic>) A schematic presentation of the α<bold>-</bold>globin locus including the genes involved in the triplication by MLPA studies. The black bar indicates the extent of the triplication. (<italic>B</italic>) MLPA is a multiplex PCR method for detecting abnormal copy numbers. The <italic>y</italic>-axis represents the relative quantity of each amplicon. The black bar indicates the area of the triplication as diagnosed by MLPA. The error bars refer to the standard deviation. The triplication begins upstream of the DNase I hypersensitive site HS-40 (an upstream regulatory element of <italic>HBA</italic> cluster genes) and ends downstream to the <italic>HBQ1</italic> gene. *The reference genes (gray background) are located in other areas of the genome and serve as a validation of the technique in each run.</p></caption><graphic xlink:href="Steinberg-ShemerMCS001941_F3"></graphic></fig><table-wrap id="STEINBERG-SHEMERMCS001941TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Rare copy number variants identified in proband</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" span="1"/><col align="char" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Chromosome</th><th align="center" colspan="1" rowspan="1">Start</th><th align="center" colspan="1" rowspan="1">End</th><th align="center" colspan="1" rowspan="1">Event</th><th align="center" colspan="1" rowspan="1">No. of exons</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">92,251,714</td><td colspan="1" rowspan="1">92,433,879</td><td colspan="1" rowspan="1">Duplication</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">109,271,481</td><td colspan="1" rowspan="1">109,287,355</td><td colspan="1" rowspan="1">Deletion</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">177,171,344</td><td colspan="1" rowspan="1">177,210,906</td><td colspan="1" rowspan="1">Duplication</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">610,047</td><td colspan="1" rowspan="1">656,996</td><td colspan="1" rowspan="1">Deletion</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">100,606,688</td><td colspan="1" rowspan="1">100,610,365</td><td colspan="1" rowspan="1">Deletion</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">89,664,289</td><td colspan="1" rowspan="1">89,715,334</td><td colspan="1" rowspan="1">Duplication</td><td colspan="1" rowspan="1">9</td></tr><tr><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">160,473</td><td colspan="1" rowspan="1">240,621</td><td colspan="1" rowspan="1">Duplication</td><td colspan="1" rowspan="1">23</td></tr><tr><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">19,532,927</td><td colspan="1" rowspan="1">19,536,653</td><td colspan="1" rowspan="1">Deletion</td><td colspan="1" rowspan="1">4</td></tr></tbody></table></table-wrap></sec><sec id="s2c"><title>Treatment Outcomes</title><p>Thalassemia results from imbalance in the levels of α- and β-globin chains. In β-thalassemia, the α/β globin ratio is increased, resulting in excess α-globin, which is toxic to red blood cell precursors. Generally, β-thalassemia symptoms can be partially ameliorated by mutations that reduce the overall synthesis of α-globin but worsened by mutations that result in excess α-globin.</p><p>The combination of α-thalassemia triplications and heterozygous β-thalassemia mutations are known to result in a clinical presentation of thalassemia intermedia (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C11">Galanello et al. 1983</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C37">Thein et al. 1984</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C14">Henni et al. 1985</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C3">Camaschella et al. 1987</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C19">Kulozik et al. 1987</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C28">Oron et al. 1994</xref>, <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C38">Traeger-Synodinos et al. 1996</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C12">Giordano et al. 2009</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C9">Farashi et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C25">Mehta et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C4">Clark et al. 2016</xref>). In this patient, the diagnosis of thalassemia intermedia is in agreement with his clinical workup, including microcytic anemia and splenomegaly. Having determined the correct diagnosis of thalassemia intermedia in our patient helped guide his clinical management, including decisions regarding indications for blood transfusion, monitoring and treating complications of chronic hemolysis and of iron overload, periodic assessment for pulmonary hypertension, and consideration for treatment with agents that induce fetal hemoglobin (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C36">Taher et al. 2013</xref>), as the increased production of γ-globin improves the imbalance of the α- and β-globin chains (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C27">Musallam et al. 2013</xref>). Most importantly, as a result of a definitive molecular diagnosis, we decided to not perform a surgical splenectomy, which can ameliorate the severity of certain anemias (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C20">Lacy et al. 2016</xref>) but instead carries a high risk of postsplenectomy complications in thalassemia intermedia patients (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C17">Karimi et al. 2011</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C36">Taher et al. 2013</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>DISCUSSION</title><p>The clinical spectrum resulting from the combination of heterozygosity for β-thalassemia and triplication of α-globin is wide and ranges from mild β-thalassemia minor to clinically significant thalassemia intermedia (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C16">Kanavakis et al. 1983</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C32">Sampietro et al. 1983</xref>, <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C11">Galanello et al. 1983</xref>, <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C37">Thein et al. 1984</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C14">Henni et al. 1985</xref>, <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C3">Camaschella et al. 1987</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C19">Kulozik et al. 1987</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C28">Oron et al. 1994</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C38">Traeger-Synodinos et al. 1996</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C2">Bianco et al. 1997</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C12">Giordano et al. 2009</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C9">Farashi et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C25">Mehta et al. 2015</xref>). Most commonly, the triplication of α-globin results from abnormal homologous recombination, generating the common α<sup>−3.7</sup> deletion and the ααα<sup>anti3.7</sup> triplication. However, larger duplications, such as the one identified here, have been described (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C13">Harteveld et al. 2008</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C15">Jiang et al. 2015</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C4">Clark et al. 2016</xref>). These larger triplications seem to uniformly result in more severe disease, at least as far as has been reported in the literature, likely because they result in the addition of two extra α-globin copies, contrasting with the ααα<sup>anti3.7</sup> triplication, which adds only one α-globin copy.</p><p>Importantly, these uncommon triplications are often missed by standard molecular technologies such as restriction endonuclease mapping and multiplex gap-PCR. Recently, three duplications of the α-globin locus that extended well beyond the locus and would be undetectable by standard approaches were identified by targeted genome sequencing (using a unique library of DNA baits) in thalassemia intermedia patients with heterozygous mutations in the β-globin gene (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C4">Clark et al. 2016</xref>). Here, we show that in addition to this approach and targeted MLPA (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C13">Harteveld et al. 2008</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C5">Colosimo et al. 2011</xref>), standard WES can also be used to identify extended α-globin CNVs. Thus, in certain cases where WES has already been performed, WES-based CNV calling provides a cost-effective approach for the identification of copy-number changes across the α-globin locus.</p><p>Notably, the clinical and laboratory details of this patient initially suggested a diagnosis of CDA, and the patient underwent a full genetic workup for all genes known to be involved in these syndromes. In agreement with our own clinical experience as well as with other recent studies, targeted or exome sequencing of clinical CDA cases occasionally results in no genetic evidence of CDA but definitive evidence of alternative hematological disorders explanative of the CDA-like phenotype (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C30">Roy et al. 2016</xref>). In these alternative disorders, stress erythropoiesis potentially leads to the CDA-like phenotypes observed, but an accurate diagnosis can often have a significant impact on clinical decision-making in these cases.</p><p>WES-based CNV calling has successfully identified pathogenic variants in a number of genetically unsolved cases. Variants identified are typically deletions, but here we show that pathogenic increases in copy number can also be successfully identified in WES. More generally, we suggest that WES-based CNV calling should be a standard part of any WES pipeline and putative CNVs should be carefully investigated when standard variant analyses are unrevealing prior to moving to more expensive approaches such as WGS.</p></sec><sec id="s4" sec-type="methods"><title>METHODS</title><p>Peripheral blood and bone marrow samples were collected after informed consent was obtained. Bone marrow aspiration smears were stained with Hematek (Siemens).</p><sec id="s4a"><title>Sequencing and Analysis</title><p>DNA was extracted by DNA isolation kit from mammalian blood (Roche) according to the manufacturer's instructions. WES was performed as previously described with the exception that Illumina ICE baits were used for DNA capture (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C34">Sankaran et al. 2012</xref>). Coverage across the consensus coding DNA sequences (downloaded from UCSC genome browser on December 13, 2015) plus an additional 20 nt on each side of the exons was calculated using Picard tools (<xref ref-type="table" rid="STEINBERG-SHEMERMCS001941TB1">Table 1</xref>). The variant call file was annotated with Variant Effect Predictor v83 (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C24">McLaren et al. 2016</xref>). The genome analysis toolkit (GATK) and Bcftools were then used to identify rare variants (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C8">DePristo et al. 2011</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C22">Li 2011</xref>; <xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C21">Lek et al. 2016</xref>). No rare (defined as 0.01% allele frequency in ExAC) damaging (missense or loss-of-function) mutations were present in the patient in any of the known CDA or other red cell disorder genes (<italic>ANK1, SPTB, SPTA1, SLC4A1, EPB42, EPB41, PIEZO1, KCNN4, GLUT1, G6PD, PKLR, NT5C3A, HK1, GPI, PGK1, ALDOA, TPI1, PFKM, ALAS2, FECH, UROS, CDAN1, SEC23B, KIF23, KLF1, GATA1, HBB, HBA1, HBA2, RPS19, RPL5, RPL11, RPL35A, RPS26, RPS24, RPS17, RPS7, RPS10, RPL26, RPS29, RPS28, RPS27, RPL27, RPL15, RPL31, TSR2</italic>) with the exception of IVS-I-110:G&gt;A in <italic>HBB</italic>. Copy-number variant analysis was performed using XHMM (<xref ref-type="bibr" rid="STEINBERG-SHEMERMCS001941C10">Fromer et al. 2012</xref>). Controls were 216 unrelated cases from a Diamond–Blackfan anemia cohort that were sequenced at the Broad Institute at the same time as the case reported here. Suggested XHMM parameters were used with the exception that CNVs were called using both unique and multimapped exon read coverages (GATK DepthOfCoverage parameters “--minMappingQuality 20” and “--minMappingQuality 0”, respectively), because <italic>HBA1</italic> and <italic>HBA2</italic> are highly homologous.</p></sec><sec id="s4b"><title>Multiplex Ligation-Dependent Probe Amplification</title><p>MLPA was performed using the commercially available kit Salsa MLPA P140B HBA (MCR-Holland) following the manufacturer's instructions. The amplified fragments were separated by capillary electrophoresis in the 3130XL Genetic Analyzer, ABI PRISM (Applied Biosystems). Quantitative data were obtained with Gene-Mapper v3.7 software (Applied Biosystems).</p></sec></sec><sec id="s5"><title>ADDITIONAL INFORMATION</title><sec id="s5a"><title>Data Deposition and Access</title><p>Whole-exome sequencing data have been deposited in the dbGaP database (<uri xlink:href="http://www.ncbi.nlm.nih.gov/gap">http://www.ncbi.nlm.nih.gov/gap</uri>) under the accession number phs000474.v3.p2. The HBB variant has been submitted to ClinVar (<uri xlink:href="https://www.ncbi.nlm.nih.gov/clinvar">https://www.ncbi.nlm.nih.gov/clinvar</uri>), accession number SCV000579457.</p></sec><sec id="s5b"><title>Ethics Statement</title><p>The study was approved by the Institutional Review Board (IRB) of the Rabin Medical Center (Study number 0031-11). The patient provided a written consent for the genetic analysis. The IRB allows for the genetic testing performed to be analyzed and deposited, as indicated.</p></sec><sec id="s5c"><title>Author Contributions</title><p>O.S.S., R.L., and H.T. contributed to patient recruitment and phenotyping. J.C.U. and V.G.S. contributed to sequence data analysis and interpretation. O.S.S., J.C.U., S.N.L., T.K., O.D., R.L., V.G.S., and H.T. contributed to functional evaluation of the variant. O.S.S., J.C.U., V.G.S., and H.T. contributed to writing the initial draft of the manuscript. All authors contributed to revising the manuscript and reviewing the final draft.</p></sec><sec id="s5d"><title>Funding</title><p>This work was supported by the National Institutes of Health grants R01 DK103794 (National Institute of Diabetes and Digestive and Kidney Diseases) and R33 HL120791 (National Heart, Lung, and Blood Institute) (to V.G.S.).</p></sec><sec id="s5e"><title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Supplemental Material</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_3_6_a001941__index.html"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_mcs.a001941_Supplemental_Table_1.docx" xlink:role="associated-file"></media>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supplementary-material">
<p>[Supplemental material is available for this article.]</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="STEINBERG-SHEMERMCS001941C1">
<mixed-citation publication-type="journal"><name><surname>Belkadi</surname><given-names>A</given-names></name>, <name><surname>Bolze</surname><given-names>A</given-names></name>, <name><surname>Itan</surname><given-names>Y</given-names></name>, <name><surname>Cobat</surname><given-names>A</given-names></name>, <name><surname>Vincent</surname><given-names>QB</given-names></name>, <name><surname>Antipenko</surname><given-names>A</given-names></name>, <name><surname>Shang</surname><given-names>L</given-names></name>, <name><surname>Boisson</surname><given-names>B</given-names></name>, <name><surname>Casanova</surname><given-names>JL</given-names></name>, <name><surname>Abel</surname><given-names>L</given-names></name>. <year>2015</year>
<article-title>Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants</article-title>. <source/>Proc Natl Acad Sci
<volume>112</volume>: <fpage>5473</fpage>–<lpage>5478</lpage>.<pub-id pub-id-type="pmid">25827230</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C2">
<mixed-citation publication-type="journal"><name><surname>Bianco</surname><given-names>I</given-names></name>, <name><surname>Lerone</surname><given-names>M</given-names></name>, <name><surname>Foglietta</surname><given-names>E</given-names></name>, <name><surname>Deidda</surname><given-names>G</given-names></name>, <name><surname>Cappabianca</surname><given-names>MP</given-names></name>, <name><surname>Morlupi</surname><given-names>L</given-names></name>, <name><surname>Ponzini</surname><given-names>D</given-names></name>, <name><surname>Grisanti</surname><given-names>P</given-names></name>, <name><surname>Di Biagio</surname><given-names>P</given-names></name>, <name><surname>Amato</surname><given-names>A</given-names></name>, <etal></etal>
<year>1997</year>
<article-title>Phenotypes of individuals with a β thal classical allele associated either with a β thal silent allele or with α globin gene triplication</article-title>. <source/>Haematologica
<volume>82</volume>: <fpage>513</fpage>–<lpage>525</lpage>.<pub-id pub-id-type="pmid">9407714</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C3">
<mixed-citation publication-type="journal"><name><surname>Camaschella</surname><given-names>C</given-names></name>, <name><surname>Bertero</surname><given-names>MT</given-names></name>, <name><surname>Serra</surname><given-names>A</given-names></name>, <name><surname>Dall'Acqua</surname><given-names>M</given-names></name>, <name><surname>Gasparini</surname><given-names>P</given-names></name>, <name><surname>Trento</surname><given-names>M</given-names></name>, <name><surname>Vettore</surname><given-names>L</given-names></name>, <name><surname>Perona</surname><given-names>G</given-names></name>, <name><surname>Saglio</surname><given-names>G</given-names></name>, <name><surname>Mazza</surname><given-names>U</given-names></name>. <year>1987</year>
<article-title>A benign form of thalassaemia intermedia may be determined by the interaction of triplicated α locus and heterozygous β-thalassaemia</article-title>. <source/>Br J Haematol
<volume>66</volume>: <fpage>103</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">3593644</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C4">
<mixed-citation publication-type="journal"><name><surname>Clark</surname><given-names>B</given-names></name>, <name><surname>Shooter</surname><given-names>C</given-names></name>, <name><surname>Smith</surname><given-names>F</given-names></name>, <name><surname>Brawand</surname><given-names>D</given-names></name>, <name><surname>Steedman</surname><given-names>L</given-names></name>, <name><surname>Oakley</surname><given-names>M</given-names></name>, <name><surname>Rushton</surname><given-names>P</given-names></name>, <name><surname>Rooks</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Drousiotou</surname><given-names>A</given-names></name>, <etal></etal>
<year>2016</year>
<article-title>β Thalassaemia intermedia due to co-inheritance of three unique α globin cluster duplications characterised by next generation sequencing analysis</article-title>. <source/>Br J Haematol
<pub-id pub-id-type="doi">10.1111/bjh.14294</pub-id>.</mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C5">
<mixed-citation publication-type="journal"><name><surname>Colosimo</surname><given-names>A</given-names></name>, <name><surname>Gatta</surname><given-names>V</given-names></name>, <name><surname>Guida</surname><given-names>V</given-names></name>, <name><surname>Leodori</surname><given-names>E</given-names></name>, <name><surname>Foglietta</surname><given-names>E</given-names></name>, <name><surname>Rinaldi</surname><given-names>S</given-names></name>, <name><surname>Cappabianca</surname><given-names>MP</given-names></name>, <name><surname>Amato</surname><given-names>A</given-names></name>, <name><surname>Stuppia</surname><given-names>L</given-names></name>, <name><surname>Dallapiccola</surname><given-names>B</given-names></name>. <year>2011</year>
<article-title>Application of MLPA assay to characterize unsolved α-globin gene rearrangements</article-title>. <source/>Blood Cells Mol Dis
<volume>46</volume>: <fpage>139</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">21190870</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C6">
<mixed-citation publication-type="journal"><name><surname>de Ligt</surname><given-names>J</given-names></name>, <name><surname>Boone</surname><given-names>PM</given-names></name>, <name><surname>Pfundt</surname><given-names>R</given-names></name>, <name><surname>Vissers</surname><given-names>LE</given-names></name>, <name><surname>Richmond</surname><given-names>T</given-names></name>, <name><surname>Geoghegan</surname><given-names>J</given-names></name>, <name><surname>O'Moore</surname><given-names>K</given-names></name>, <name><surname>de Leeuw</surname><given-names>N</given-names></name>, <name><surname>Shaw</surname><given-names>C</given-names></name>, <name><surname>Brunner</surname><given-names>HG</given-names></name>, <etal></etal>
<year>2013</year>
<article-title>Detection of clinically relevant copy number variants with whole-exome sequencing</article-title>. <source/>Hum Mutat
<volume>34</volume>: <fpage>1439</fpage>–<lpage>1448</lpage>.<pub-id pub-id-type="pmid">23893877</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C7">
<mixed-citation publication-type="journal"><name><surname>de Mare</surname><given-names>A</given-names></name>, <name><surname>Groeneger</surname><given-names>AH</given-names></name>, <name><surname>Schuurman</surname><given-names>S</given-names></name>, <name><surname>van den Bergh</surname><given-names>FA</given-names></name>, <name><surname>Slomp</surname><given-names>J</given-names></name>. <year>2010</year>
<article-title>A rapid single-tube multiplex polymerase chain reaction assay for the seven most prevalent α-thalassemia deletions and α (anti 3.7) α-globin gene triplication</article-title>. <source/>Hemoglobin
<volume>34</volume>: <fpage>184</fpage>–<lpage>190</lpage>.<pub-id pub-id-type="pmid">20353357</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C8">
<mixed-citation publication-type="journal"><name><surname>DePristo</surname><given-names>MA</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Poplin</surname><given-names>R</given-names></name>, <name><surname>Garimella</surname><given-names>KV</given-names></name>, <name><surname>Maguire</surname><given-names>JR</given-names></name>, <name><surname>Hartl</surname><given-names>C</given-names></name>, <name><surname>Philippakis</surname><given-names>AA</given-names></name>, <name><surname>del Angel</surname><given-names>G</given-names></name>, <name><surname>Rivas</surname><given-names>MA</given-names></name>, <name><surname>Hanna</surname><given-names>M</given-names></name>, <etal></etal>
<year>2011</year>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>. <source/>Nat Genet
<volume>43</volume>: <fpage>491</fpage>–<lpage>498</lpage>.<pub-id pub-id-type="pmid">21478889</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C9">
<mixed-citation publication-type="journal"><name><surname>Farashi</surname><given-names>S</given-names></name>, <name><surname>Bayat</surname><given-names>N</given-names></name>, <name><surname>Faramarzi Garous</surname><given-names>N</given-names></name>, <name><surname>Ashki</surname><given-names>M</given-names></name>, <name><surname>Montajabi Niat</surname><given-names>M</given-names></name>, <name><surname>Vakili</surname><given-names>S</given-names></name>, <name><surname>Imanian</surname><given-names>H</given-names></name>, <name><surname>Zeinali</surname><given-names>S</given-names></name>, <name><surname>Najmabadi</surname><given-names>H</given-names></name>, <name><surname>Azarkeivan</surname><given-names>A</given-names></name>. <year>2015</year>
<article-title>Interaction of an α-globin gene triplication with β-globin gene mutations in Iranian patients with β-thalassemia intermedia</article-title>. <source/>Hemoglobin
<volume>39</volume>: <fpage>201</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="pmid">26084319</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C10">
<mixed-citation publication-type="journal"><name><surname>Fromer</surname><given-names>M</given-names></name>, <name><surname>Moran</surname><given-names>JL</given-names></name>, <name><surname>Chambert</surname><given-names>K</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Bergen</surname><given-names>SE</given-names></name>, <name><surname>Ruderfer</surname><given-names>DM</given-names></name>, <name><surname>Handsaker</surname><given-names>RE</given-names></name>, <name><surname>McCarroll</surname><given-names>SA</given-names></name>, <name><surname>O'Donovan</surname><given-names>MC</given-names></name>, <name><surname>Owen</surname><given-names>MJ</given-names></name>, <etal></etal>
<year>2012</year>
<article-title>Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth</article-title>. <source/>Am J Hum Genet
<volume>91</volume>: <fpage>597</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">23040492</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C11">
<mixed-citation publication-type="journal"><name><surname>Galanello</surname><given-names>R</given-names></name>, <name><surname>Ruggeri</surname><given-names>R</given-names></name>, <name><surname>Paglietti</surname><given-names>E</given-names></name>, <name><surname>Addis</surname><given-names>M</given-names></name>, <name><surname>Melis</surname><given-names>MA</given-names></name>, <name><surname>Cao</surname><given-names>A</given-names></name>. <year>1983</year>
<article-title>A family with segregating triplicated α globin loci and β thalassemia</article-title>. <source/>Blood
<volume>62</volume>: <fpage>1035</fpage>–<lpage>1040</lpage>.<pub-id pub-id-type="pmid">6313095</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C12">
<mixed-citation publication-type="journal"><name><surname>Giordano</surname><given-names>PC</given-names></name>, <name><surname>Bakker-Verwij</surname><given-names>M</given-names></name>, <name><surname>Harteveld</surname><given-names>CL</given-names></name>. <year>2009</year>
<article-title>Frequency of α-globin gene triplications and their interaction with β-thalassemia mutations</article-title>. <source/>Hemoglobin
<volume>33</volume>: <fpage>124</fpage>–<lpage>131</lpage>.<pub-id pub-id-type="pmid">19373588</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C13">
<mixed-citation publication-type="journal"><name><surname>Harteveld</surname><given-names>CL</given-names></name>, <name><surname>Refaldi</surname><given-names>C</given-names></name>, <name><surname>Cassinerio</surname><given-names>E</given-names></name>, <name><surname>Cappellini</surname><given-names>MD</given-names></name>, <name><surname>Giordano</surname><given-names>PC</given-names></name>. <year>2008</year>
<article-title>Segmental duplications involving the α-globin gene cluster are causing β-thalassemia intermedia phenotypes in β-thalassemia heterozygous patients</article-title>. <source/>Blood Cells Mol Dis
<volume>40</volume>: <fpage>312</fpage>–<lpage>316</lpage>.<pub-id pub-id-type="pmid">18249014</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C14">
<mixed-citation publication-type="journal"><name><surname>Henni</surname><given-names>T</given-names></name>, <name><surname>Belhani</surname><given-names>M</given-names></name>, <name><surname>Morle</surname><given-names>F</given-names></name>, <name><surname>Bachir</surname><given-names>D</given-names></name>, <name><surname>Tabone</surname><given-names>P</given-names></name>, <name><surname>Colonna</surname><given-names>P</given-names></name>, <name><surname>Godet</surname><given-names>J</given-names></name>. <year>1985</year>
<article-title>α Globin gene triplication in severe heterozygous β thalassemia</article-title>. <source/>Acta Haematol
<volume>74</volume>: <fpage>236</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">3012927</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C15">
<mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>YL</given-names></name>, <name><surname>Wan</surname><given-names>JH</given-names></name>, <name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>DZ</given-names></name>. <year>2015</year>
<article-title>Association of an α-globin gene cluster duplication and heterozygous β-thalassemia in a patient with a severe thalassemia syndrome</article-title>. <source/>Hemoglobin
<volume>39</volume>: <fpage>102</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">25690803</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C16">
<mixed-citation publication-type="journal"><name><surname>Kanavakis</surname><given-names>E</given-names></name>, <name><surname>Metaxotou-Mavromati</surname><given-names>A</given-names></name>, <name><surname>Kattamis</surname><given-names>C</given-names></name>, <name><surname>Wainscoat</surname><given-names>JS</given-names></name>, <name><surname>Wood</surname><given-names>WG</given-names></name>. <year>1983</year>
<article-title>The triplicated α gene locus and β thalassaemia</article-title>. <source/>Br J Haematol
<volume>54</volume>: <fpage>201</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="pmid">6189508</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C17">
<mixed-citation publication-type="journal"><name><surname>Karimi</surname><given-names>M</given-names></name>, <name><surname>Musallam</surname><given-names>KM</given-names></name>, <name><surname>Cappellini</surname><given-names>MD</given-names></name>, <name><surname>Daar</surname><given-names>S</given-names></name>, <name><surname>El-Beshlawy</surname><given-names>A</given-names></name>, <name><surname>Belhoul</surname><given-names>K</given-names></name>, <name><surname>Saned</surname><given-names>MS</given-names></name>, <name><surname>Temraz</surname><given-names>S</given-names></name>, <name><surname>Koussa</surname><given-names>S</given-names></name>, <name><surname>Taher</surname><given-names>AT</given-names></name>. <year>2011</year>
<article-title>Risk factors for pulmonary hypertension in patients with β thalassemia intermedia</article-title>. <source/>Eur J Intern Med
<volume>22</volume>: <fpage>607</fpage>–<lpage>610</lpage>.<pub-id pub-id-type="pmid">22075289</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C18">
<mixed-citation publication-type="journal"><name><surname>Kelsen</surname><given-names>JR</given-names></name>, <name><surname>Dawany</surname><given-names>N</given-names></name>, <name><surname>Martinez</surname><given-names>A</given-names></name>, <name><surname>Grochowski</surname><given-names>CM</given-names></name>, <name><surname>Maurer</surname><given-names>K</given-names></name>, <name><surname>Rappaport</surname><given-names>E</given-names></name>, <name><surname>Piccoli</surname><given-names>DA</given-names></name>, <name><surname>Baldassano</surname><given-names>RN</given-names></name>, <name><surname>Mamula</surname><given-names>P</given-names></name>, <name><surname>Sullivan</surname><given-names>KE</given-names></name>, <etal></etal>
<year>2015</year>
<article-title>A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report</article-title>. <source/>BMC Gastroenterol
<volume>15</volume>: <fpage>160</fpage>.<pub-id pub-id-type="pmid">26581487</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C19">
<mixed-citation publication-type="journal"><name><surname>Kulozik</surname><given-names>AE</given-names></name>, <name><surname>Thein</surname><given-names>SL</given-names></name>, <name><surname>Wainscoat</surname><given-names>JS</given-names></name>, <name><surname>Gale</surname><given-names>R</given-names></name>, <name><surname>Kay</surname><given-names>LA</given-names></name>, <name><surname>Wood</surname><given-names>JK</given-names></name>, <name><surname>Weatherall</surname><given-names>DJ</given-names></name>, <name><surname>Huehns</surname><given-names>ER</given-names></name>. <year>1987</year>
<article-title>Thalassaemia intermedia: interaction of the triple α-globin gene arrangement and heterozygous β-thalassaemia</article-title>. <source/>Br J Haematol
<volume>661</volume>: <fpage>109</fpage>–<lpage>112</lpage>.</mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C20">
<mixed-citation publication-type="journal"><name><surname>Lacy</surname><given-names>JN</given-names></name>, <name><surname>Ulirsch</surname><given-names>JC</given-names></name>, <name><surname>Grace</surname><given-names>RF</given-names></name>, <name><surname>Towne</surname><given-names>MC</given-names></name>, <name><surname>Hale</surname><given-names>J</given-names></name>, <name><surname>Mohandas</surname><given-names>N</given-names></name>, <name><surname>Lux</surname><given-names>SE</given-names><suffix>IV</suffix></name>, <name><surname>Agrawal</surname><given-names>PB</given-names></name>, <name><surname>Sankaran</surname><given-names>VG</given-names></name>. <year>2016</year>
<article-title>Exome sequencing results in successful diagnosis and treatment of a severe congenital anemia</article-title>. <source/>Cold Spring Harb Mol Case Stud
<volume>2</volume>: <fpage>a000885</fpage>.<pub-id pub-id-type="pmid">27551681</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C21">
<mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>O'Donnell-Luria</surname><given-names>AH</given-names></name>, <name><surname>Ware</surname><given-names>JS</given-names></name>, <name><surname>Hill</surname><given-names>AJ</given-names></name>, <name><surname>Cummings</surname><given-names>BB</given-names></name>, <etal></etal>
<year>2016</year>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature
<volume>536</volume>: <fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C22">
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>. <year>2011</year>
<article-title>A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data</article-title>. <source/>Bioinformatics
<volume>27</volume>: <fpage>2987</fpage>–<lpage>2993</lpage>.<pub-id pub-id-type="pmid">21903627</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C23">
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>YT</given-names></name>, <name><surname>Old</surname><given-names>JM</given-names></name>, <name><surname>Miles</surname><given-names>K</given-names></name>, <name><surname>Fisher</surname><given-names>CA</given-names></name>, <name><surname>Weatherall</surname><given-names>DJ</given-names></name>, <name><surname>Clegg</surname><given-names>JB</given-names></name>. <year>2000</year>
<article-title>Rapid detection of α-thalassaemia deletions and α-globin gene triplication by multiplex polymerase chain reactions</article-title>. <source/>Br J Haematol
<volume>108</volume>: <fpage>295</fpage>–<lpage>299</lpage>.<pub-id pub-id-type="pmid">10691858</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C24">
<mixed-citation publication-type="journal"><name><surname>McLaren</surname><given-names>W</given-names></name>, <name><surname>Gil</surname><given-names>L</given-names></name>, <name><surname>Hunt</surname><given-names>SE</given-names></name>, <name><surname>Riat</surname><given-names>HS</given-names></name>, <name><surname>Ritchie</surname><given-names>GR</given-names></name>, <name><surname>Thormann</surname><given-names>A</given-names></name>, <name><surname>Flicek</surname><given-names>P</given-names></name>, <name><surname>Cunningham</surname><given-names>F</given-names></name>. <year>2016</year>
<article-title>The ensembl variant effect predictor</article-title>. <source/>Genome Biol
<volume>17</volume>: <fpage>122</fpage>.<pub-id pub-id-type="pmid">27268795</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C25">
<mixed-citation publication-type="journal"><name><surname>Mehta</surname><given-names>PR</given-names></name>, <name><surname>Upadhye</surname><given-names>DS</given-names></name>, <name><surname>Sawant</surname><given-names>PM</given-names></name>, <name><surname>Gorivale</surname><given-names>MS</given-names></name>, <name><surname>Nadkarni</surname><given-names>AH</given-names></name>, <name><surname>Shanmukhaiah</surname><given-names>C</given-names></name>, <name><surname>Ghosh</surname><given-names>K</given-names></name>, <name><surname>Colah</surname><given-names>RB</given-names></name>. <year>2015</year>
<article-title>Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes</article-title>. <source/>Ann Hematol
<volume>94</volume>: <fpage>1953</fpage>–<lpage>1958</lpage>.<pub-id pub-id-type="pmid">26319530</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C26">
<mixed-citation publication-type="journal"><name><surname>Miyatake</surname><given-names>S</given-names></name>, <name><surname>Koshimizu</surname><given-names>E</given-names></name>, <name><surname>Fujita</surname><given-names>A</given-names></name>, <name><surname>Fukai</surname><given-names>R</given-names></name>, <name><surname>Imagawa</surname><given-names>E</given-names></name>, <name><surname>Ohba</surname><given-names>C</given-names></name>, <name><surname>Kuki</surname><given-names>I</given-names></name>, <name><surname>Nukui</surname><given-names>M</given-names></name>, <name><surname>Araki</surname><given-names>A</given-names></name>, <name><surname>Makita</surname><given-names>Y</given-names></name>, <etal></etal>
<year>2015</year>
<article-title>Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden MarkovModel: an ‘exome-first’ approach</article-title>. <source/>J Hum Genet
<volume>60</volume>: <fpage>175</fpage>–<lpage>182</lpage>.<pub-id pub-id-type="pmid">25608832</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C27">
<mixed-citation publication-type="journal"><name><surname>Musallam</surname><given-names>KM</given-names></name>, <name><surname>Taher</surname><given-names>AT</given-names></name>, <name><surname>Cappellini</surname><given-names>MD</given-names></name>, <name><surname>Sankaran</surname><given-names>VG</given-names></name>. <year>2013</year>
<article-title>Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia</article-title>. <source/>Blood
<volume>121</volume>: <fpage>2199</fpage>–<lpage>2212</lpage>.<pub-id pub-id-type="pmid">23315167</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C28">
<mixed-citation publication-type="journal"><name><surname>Oron</surname><given-names>V</given-names></name>, <name><surname>Filon</surname><given-names>D</given-names></name>, <name><surname>Oppenheim</surname><given-names>A</given-names></name>, <name><surname>Rund</surname><given-names>D</given-names></name>. <year>1994</year>
<article-title>Severe thalassaemia intermedia caused by interaction of homozygosity for α-globin gene triplication with heterozygosity for β zero-thalassaemia</article-title>. <source/>Br J Haematol
<volume>86</volume>: <fpage>377</fpage>–<lpage>379</lpage>.<pub-id pub-id-type="pmid">8199028</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C29">
<mixed-citation publication-type="journal"><name><surname>Poultney</surname><given-names>CS</given-names></name>, <name><surname>Goldberg</surname><given-names>AP</given-names></name>, <name><surname>Drapeau</surname><given-names>E</given-names></name>, <name><surname>Kou</surname><given-names>Y</given-names></name>, <name><surname>Harony-Nicolas</surname><given-names>H</given-names></name>, <name><surname>Kajiwara</surname><given-names>Y</given-names></name>, <name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>Durand</surname><given-names>S</given-names></name>, <name><surname>Stevens</surname><given-names>C</given-names></name>, <name><surname>Rehnström</surname><given-names>K</given-names></name>, <etal></etal>
<year>2013</year>
<article-title>Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder</article-title>. <source/>Am J Hum Genet
<volume>93</volume>: <fpage>607</fpage>–<lpage>619</lpage>.<pub-id pub-id-type="pmid">24094742</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C30">
<mixed-citation publication-type="journal"><name><surname>Roy</surname><given-names>NB</given-names></name>, <name><surname>Wilson</surname><given-names>EA</given-names></name>, <name><surname>Henderson</surname><given-names>S</given-names></name>, <name><surname>Wray</surname><given-names>K</given-names></name>, <name><surname>Babbs</surname><given-names>C</given-names></name>, <name><surname>Okoli</surname><given-names>S</given-names></name>, <name><surname>Atoyebi</surname><given-names>W</given-names></name>, <name><surname>Mixon</surname><given-names>A</given-names></name>, <name><surname>Cahill</surname><given-names>MR</given-names></name>, <name><surname>Carey</surname><given-names>P</given-names></name>, <etal></etal>
<year>2016</year>
<article-title>A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias</article-title>. <source/>Br J Haematol
<volume>175</volume>: <fpage>318</fpage>–<lpage>330</lpage>.<pub-id pub-id-type="pmid">27432187</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C31">
<mixed-citation publication-type="journal"><name><surname>Samarakoon</surname><given-names>PS</given-names></name>, <name><surname>Sorte</surname><given-names>HS</given-names></name>, <name><surname>Kristiansen</surname><given-names>BE</given-names></name>, <name><surname>Skodje</surname><given-names>T</given-names></name>, <name><surname>Sheng</surname><given-names>Y</given-names></name>, <name><surname>Tjønnfjord</surname><given-names>GE</given-names></name>, <name><surname>Stadheim</surname><given-names>B</given-names></name>, <name><surname>Stray-Pedersen</surname><given-names>A</given-names></name>, <name><surname>Rødningen</surname><given-names>OK</given-names></name>, <name><surname>Lyle</surname><given-names>R</given-names></name>. <year>2014</year>
<article-title>Identification of copy number variants from exome sequence data</article-title>. <source/>BMC Genomics
<volume>15</volume>: <fpage>661</fpage>.<pub-id pub-id-type="pmid">25102989</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C32">
<mixed-citation publication-type="journal"><name><surname>Sampietro</surname><given-names>M</given-names></name>, <name><surname>Cazzola</surname><given-names>M</given-names></name>, <name><surname>Cappellini</surname><given-names>MD</given-names></name>, <name><surname>Fiorelli</surname><given-names>G</given-names></name>. <year>1983</year>
<article-title>The triplicated α-gene locus and heterozygous β thalassaemia: a case of thalassaemia intermedia</article-title>. <source/>Br J Haematol
<volume>55</volume>: <fpage>709</fpage>–<lpage>710</lpage>.<pub-id pub-id-type="pmid">6671089</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C33">
<mixed-citation publication-type="journal"><name><surname>Sankaran</surname><given-names>VG</given-names></name>, <name><surname>Gallagher</surname><given-names>PG</given-names></name>. <year>2013</year>
<article-title>Applications of high-throughput DNA sequencing to benign hematology</article-title>. <source/>Blood
<volume>122</volume>: <fpage>3575</fpage>–<lpage>3582</lpage>.<pub-id pub-id-type="pmid">24021670</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C34">
<mixed-citation publication-type="journal"><name><surname>Sankaran</surname><given-names>VG</given-names></name>, <name><surname>Ghazvinian</surname><given-names>R</given-names></name>, <name><surname>Do</surname><given-names>R</given-names></name>, <name><surname>Thiru</surname><given-names>P</given-names></name>, <name><surname>Vergilio</surname><given-names>JA</given-names></name>, <name><surname>Beggs</surname><given-names>AH</given-names></name>, <name><surname>Sieff</surname><given-names>CA</given-names></name>, <name><surname>Orkin</surname><given-names>SH</given-names></name>, <name><surname>Nathan</surname><given-names>DG</given-names></name>, <name><surname>Lander</surname><given-names>ES</given-names></name>, <etal></etal>
<year>2012</year>
<article-title>Exome sequencing identifies <italic>GATA1</italic> mutations resulting in Diamond–Blackfan anemia</article-title>. <source/>J Clin Invest
<volume>122</volume>: <fpage>2439</fpage>–<lpage>2443</lpage>.<pub-id pub-id-type="pmid">22706301</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C35">
<mixed-citation publication-type="journal"><name><surname>Sankaran</surname><given-names>VG</given-names></name>, <name><surname>Ulirsch</surname><given-names>JC</given-names></name>, <name><surname>Tchaikovskii</surname><given-names>V</given-names></name>, <name><surname>Ludwig</surname><given-names>LS</given-names></name>, <name><surname>Wakabayashi</surname><given-names>A</given-names></name>, <name><surname>Kadirvel</surname><given-names>S</given-names></name>, <name><surname>Lindsley</surname><given-names>RC</given-names></name>, <name><surname>Bejar</surname><given-names>R</given-names></name>, <name><surname>Shi</surname><given-names>J</given-names></name>, <name><surname>Lovitch</surname><given-names>SB</given-names></name>, <etal></etal>
<year>2015</year>
<article-title>X-linked macrocytic dyserythropoietic anemia in females with an <italic>ALAS2</italic> mutation</article-title>. <source/>J Clin Invest
<volume>125</volume>: <fpage>1665</fpage>–<lpage>1669</lpage>.<pub-id pub-id-type="pmid">25705881</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C36">
<mixed-citation publication-type="other"><name><surname>Taher</surname><given-names>A</given-names></name>, <name><surname>Vichinsky</surname><given-names>E</given-names></name>, <name><surname>Musallam</surname><given-names>K</given-names></name>, <name><surname>Cappellini</surname><given-names>MD</given-names></name>, <name><surname>Viprakasit</surname><given-names>V</given-names></name>, authors; <name><surname>Weatherall</surname><given-names>D</given-names></name>, editor. <year>2013</year>
<comment>Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). Thalassaemia International Federation (TIF) publication no. 19</comment>.</mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C37">
<mixed-citation publication-type="journal"><name><surname>Thein</surname><given-names>SL</given-names></name>, <name><surname>Al-Hakim</surname><given-names>I</given-names></name>, <name><surname>Hoffbrand</surname><given-names>AV</given-names></name>. <year>1984</year>
<article-title>Thalassaemia intermedia: a new molecular basis</article-title>. <source/>Br J Haematol
<volume>56</volume>: <fpage>333</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">6318796</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C38">
<mixed-citation publication-type="journal"><name><surname>Traeger-Synodinos</surname><given-names>J</given-names></name>, <name><surname>Kanavakis</surname><given-names>E</given-names></name>, <name><surname>Vrettou</surname><given-names>C</given-names></name>, <name><surname>Maragoudaki</surname><given-names>E</given-names></name>, <name><surname>Michael</surname><given-names>T</given-names></name>, <name><surname>Metaxotou-Mavromati</surname><given-names>A</given-names></name>, <name><surname>Kattamis</surname><given-names>C</given-names></name>. <year>1996</year>
<article-title>The triplicated α-globin gene locus in β-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studies</article-title>. <source/>Br J Haematol
<volume>95</volume>: <fpage>467</fpage>–<lpage>471</lpage>.<pub-id pub-id-type="pmid">8943886</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C39">
<mixed-citation publication-type="journal"><name><surname>Vichinsky</surname><given-names>E</given-names></name>. <year>2016</year>
<article-title>Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management</article-title>. <source/>Curr Med Res Opin
<volume>32</volume>: <fpage>191</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">26479125</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C40">
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Reid</surname><given-names>JG</given-names></name>, <name><surname>Bainbridge</surname><given-names>MN</given-names></name>, <name><surname>Willis</surname><given-names>A</given-names></name>, <name><surname>Ward</surname><given-names>PA</given-names></name>, <name><surname>Braxton</surname><given-names>A</given-names></name>, <name><surname>Beuten</surname><given-names>J</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Niu</surname><given-names>Z</given-names></name>, <etal></etal>
<year>2013</year>
<article-title>Clinical whole-exome sequencing for the diagnosis of Mendelian disorders</article-title>. <source/>N Engl J Med
<volume>369</volume>: <fpage>1502</fpage>–<lpage>1511</lpage>.<pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="STEINBERG-SHEMERMCS001941C41">
<mixed-citation publication-type="journal"><name><surname>Young</surname><given-names>K</given-names></name>, <name><surname>Margulies</surname><given-names>L</given-names></name>, <name><surname>Donovan-Peluso</surname><given-names>M</given-names></name>, <name><surname>Clyne</surname><given-names>J</given-names></name>, <name><surname>Driscoll</surname><given-names>MC</given-names></name>, <name><surname>Dobkin</surname><given-names>C</given-names></name>, <name><surname>Leibowitz</surname><given-names>D</given-names></name>, <name><surname>Russo</surname><given-names>G</given-names></name>, <name><surname>Schiliro</surname><given-names>G</given-names></name>, <name><surname>Bank</surname><given-names>A</given-names></name>. <year>1985</year>
<article-title>Structure and expression of two β genes in a β thalassemia homozygote<italic>.</italic></article-title>
<source/>J Mol Appl Genet
<volume>3</volume>: <fpage>1</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">4009093</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>